ScoreWhy is Neuland Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 16.00%
2
Company has a Debt to Equity ratio (avg) of 0.07 times
3
Healthy long term growth as Operating profit has grown by an annual rate 35.13%
4
With a growth in Net Sales of 26.86%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- PBT LESS OI(Q) At Rs 189.36 cr has Grown at 65.1% (vs previous 4Q average)
- PAT(Q) At Rs 147.67 cr has Grown at 62.3% (vs previous 4Q average)
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 354.96 cr
5
High Institutional Holdings at 37.6%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.3% over the previous quarter.
6
Consistent Returns over the last 3 years
- Along with generating 67.94% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Neuland Labs. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Neuland Labs. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Neuland Labs.
67.94%
1.75
38.75%
Sensex
-1.97%
-0.15
13.56%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.64%
EBIT Growth (5y)
35.13%
EBIT to Interest (avg)
20.28
Debt to EBITDA (avg)
0.76
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.97
Tax Ratio
25.62%
Dividend Payout Ratio
5.95%
Pledged Shares
2.29%
Institutional Holding
37.60%
ROCE (avg)
20.13%
ROE (avg)
16.00%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
56
Industry P/E
37
Price to Book Value
14.81
EV to EBIT
41.69
EV to EBITDA
36.33
EV to Capital Employed
15.22
EV to Sales
11.69
PEG Ratio
0.20
Dividend Yield
0.16%
ROCE (Latest)
26.51%
ROE (Latest)
19.42%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
PBT LESS OI(Q)
At Rs 189.36 cr has Grown at 65.1% (vs previous 4Q average
PAT(Q)
At Rs 147.67 cr has Grown at 62.3% (vs previous 4Q average
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 354.96 cr
NET SALES(Q)
At Rs 641.58 cr has Grown at 26.9% (vs previous 4Q average
-4What is not working for the Company
INTEREST(9M)
At Rs 20.97 cr has Grown at 70.49%
Loading Valuation Snapshot...
Here's what is working for Neuland Labs.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 189.36 cr has Grown at 65.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 114.70 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 147.67 cr has Grown at 62.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 91.00 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 641.58 cr has Grown at 26.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 505.75 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 354.96 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Neuland Labs.
Interest - Nine Monthly
At Rs 20.97 cr has Grown at 70.49%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
